C3ORF33 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.288000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.831200E-01
Normal-vs-Stage2
3.029200E-01
Normal-vs-Stage3
9.683500E-02
Normal-vs-Stage4
7.884000E-01
Stage1-vs-Stage2
5.834200E-02
Stage1-vs-Stage3
4.082200E-02
Stage1-vs-Stage4
5.348200E-01
Stage2-vs-Stage3
3.767200E-01
Stage2-vs-Stage4
4.260000E-01
Stage3-vs-Stage4
1.381230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.593200E-01
Normal-vs-AfricanAmerican
9.848200E-01
Normal-vs-Asian
9.035900E-02
Caucasian-vs-AfricanAmerican
3.126200E-01
Caucasian-vs-Asian
1.265240E-01
AfricanAmerican-vs-Asian
5.150000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.834600E-01
Normal-vs-Female
5.091000E-01
Male-vs-Female
3.083600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.965800E-01
Normal-vs-Age(41-60Yrs)
5.043200E-01
Normal-vs-Age(61-80Yrs)
4.054000E-01
Normal-vs-Age(81-100Yrs)
3.287000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.145000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.124000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.858000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.250000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.486600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.714000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.217150E-01
Normal-vs-Daily Drinker
1.402420E-01
Normal-vs-Weekly Drinker
3.727800E-01
Normal-vs-Occasional Drinker
4.497400E-01
Normal-vs-Social Drinker
4.281800E-01
Non Drinker-vs-Daily Drinker
3.373000E-01
Non Drinker-vs-Weekly Drinker
9.064200E-01
Non Drinker-vs-Occasional Drinker
3.627200E-01
Non Drinker-vs-Social Drinker
8.588000E-01
Daily Drinker-vs-Weekly Drinker
6.342200E-01
Daily Drinker-vs-Occasional Drinker
1.546030E-01
Daily Drinker-vs-Social Drinker
4.359600E-01
Weekly Drinker-vs-Occasional Drinker
5.094000E-01
Weekly Drinker-vs-Social Drinker
8.229600E-01
Occasional Drinker-vs-Social Drinker
6.816000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.286380E-01
Normal-vs-Grade 2
1.185780E-01
Normal-vs-Grade 3
1.494020E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.969600E-01
Grade 1-vs-Grade 3
1.058000E-01
Grade 1-vs-Grade 4
1.286380E-01
Grade 2-vs-Grade 3
4.883800E-01
Grade 2-vs-Grade 4
1.185780E-01
Grade 3-vs-Grade 4
1.494020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.101800E-02
Normal-vs-NonDiabetic
5.167000E-01
Diabetic-vs-NonDiabetic
4.301600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.104600E-01
Normal-vs-NoPancreatitis
4.029200E-01
Pancreatitis-vs-NoPancreatitis
5.162400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.289600E-01
Normal-vs-N1
3.322200E-01
N0-vs-N1
2.428400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.220000E-01
Normal-vs-TP53-NonMutant
8.367800E-01
TP53-Mutant-vs-TP53-NonMutant
6.295700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
